An Act relative to treatment for substance use disorder
Generates a plain-language summary of the bill text and history.
| Date | Branch | Action |
|---|---|---|
| 3/30/2026 | House | Accompanied a study order, see H5319↗ (under House Rule 27) |
| — | House | Reported by committee to Clerk’s Office for processing, will accompany a study order |
| 9/26/2025 | Joint | Hearing scheduled for 10/06/2025 from 01:00 PM-05:00 PM in A-2 |
| 2/27/2025 | Senate | Senate concurred |
| 2/27/2025 | House | Referred to the committee on Mental Health, Substance Use and Recovery |
| Committee | Recommendation | Vote |
|---|---|---|
| J18 | Accompanied | — |
½ of chapter 111 of the General Laws, as appearing in the 2022 Official Edition, is hereby amended by striking subsection (d) in its entirety and inserting the following thereof:- (d) If a person has received a substance abuse evaluation and returns to an acute care hospital or emergency satellite facility within seven days of receipt of such evaluation suffering from an opiate-related overdose or has recently been administered naloxone, the attending physician may authorize the restraint of such person and apply for the treatment of such person for a 3-day period at a facility authorized for such purposes by the department of public health or the department of mental health.
Section 51 ½ of chapter 111 of the General Laws, as appearing in the 2022 Official Edition, is hereby amended by striking subsection (d) in its entirety and inserting the following thereof:- (d) If a person has received a substance abuse evaluation and returns to an acute care hospital or emergency satellite facility within seven days of receipt of such evaluation suffering from an opiate-related overdose or has recently been administered naloxone, the attending physician may authorize the restraint of such person and apply for the treatment of such person for a 3-day period at a facility authorized for such purposes by the department of public health or the department of mental health.